Author:
Knipper S.,Mandel P.,v. Amsberg G.,Strölin P.,Graefen M.,Steuber T.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. de Bono J, Oudard S, Ozguroglu M, Hansen S, Machiels J, Kocak I, Gravis G, Bodrogi I, Mackenzie M, Shen L, Roessner M, Gupta S, Sartor A, TROPIC Investigators (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376(9747):1147–1154
2. Crawford E, Eisenberger M, McLeod D, Spaulding J, Benson R, Dorr F, Blumenstein B, Davis M, Goodman P (1989) A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321:419–424
3. Dickinson P, Peel D, Sundar S (2012) Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate. Br J Cancer 106:1464–1465
4. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247
5. Gelbe Liste. Pharmindex (2017) Fachinformation: Cyclophosphamid HEXAL® 500 mg Pulver zur Herstellung einer Injektions‑/Infusionslösung.
https://www.gelbe-liste.de/produkte/cyclophosphamid-hexal-500-mg-pulver-zur-herstellung-einer-injektions-infusionsloesung_897186/fachinformation#collapse2
. Zugegriffen: 7. Jan. 2018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献